Pyrrolo[1,2-a]pyrazine derivatives as 5HT1A ligands
US6284757A · kind A · utility
27Cited by
1References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 11, 1999 |
| Grant date | Sep 4, 2001 |
| Priority date | — |
| Expiry date | Aug 11, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of compounds of formula I ##STR1## PA1 wherein R.sub.1, R.sub.2, R.sub.3, X, m and n are defined as in the specification, and their pharmaceutically acceptable salts, for the treatment of disorders of the serotonin system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.